Skip to content
AdminAug 1, 2023< 1 min read

xCures to Contribute Data to Support Aetion®’s Collaboration with FDA

In a step forward for healthcare research, xCures is pleased to announce that it will support Aetion®'s collaboration with the US Food and Drug Administration (FDA) Oncology Center of Excellence (OCE). As part of this partnership, xCures will provide Aetion with data to support their research collaboration agreement with OCE which centers on using real-world data (RWD) to assess real-world oncology endpoints and measure and address health disparities.

Read More

Admin

RELATED ARTICLES

AdminJan 24, 20232 min read

Aetion Collaborates With FDA to Explore Oncology RWD for Regulatory Science Research

NEW YORK, January 24, 2023/ — Aetion, the global leader in real-world evidence (RWE) technology and analytics, today announced ...
Start Reading
AdminOct 15, 20194 min read

McKesson and Aetion collaborate to advance cancer research with real-world data

IRVING, Texas & NEW YORK—(BUSINESS WIRE)—Today Aetion and McKesson announced a strategic collaboration focused on advancing ...
Start Reading
AdminSep 13, 20232 min read

Aetion to Assess the Potential for Greater Inclusivity in Randomized Controlled Trials within the Field of Oncology

NEW YORK, NY, September 13, 2023— Aetion®, the global leader in real-world evidence (RWE) technology and analytics, announced ...
Start Reading